NO20080219L - Fentanylformulering som inneholder en essensiell olje - Google Patents

Fentanylformulering som inneholder en essensiell olje

Info

Publication number
NO20080219L
NO20080219L NO20080219A NO20080219A NO20080219L NO 20080219 L NO20080219 L NO 20080219L NO 20080219 A NO20080219 A NO 20080219A NO 20080219 A NO20080219 A NO 20080219A NO 20080219 L NO20080219 L NO 20080219L
Authority
NO
Norway
Prior art keywords
essential oil
formulation containing
fentanyl formulation
fentanyl
formulations
Prior art date
Application number
NO20080219A
Other languages
English (en)
Norwegian (no)
Inventor
Clive Booles
Calvin Ross
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20080219L publication Critical patent/NO20080219L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20080219A 2005-07-08 2008-01-14 Fentanylformulering som inneholder en essensiell olje NO20080219L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0514043.9A GB0514043D0 (en) 2005-07-08 2005-07-08 Fentanyl formulation
PCT/GB2006/002526 WO2007007059A1 (en) 2005-07-08 2006-07-07 Fentanyl formulation containing an essential oil

Publications (1)

Publication Number Publication Date
NO20080219L true NO20080219L (no) 2008-02-05

Family

ID=34896944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080219A NO20080219L (no) 2005-07-08 2008-01-14 Fentanylformulering som inneholder en essensiell olje

Country Status (15)

Country Link
EP (1) EP1904032B1 (de)
JP (1) JP2009500387A (de)
KR (1) KR20080044232A (de)
CN (1) CN101247788A (de)
AT (1) ATE490762T1 (de)
AU (1) AU2006268052A1 (de)
BR (1) BRPI0612771A2 (de)
CA (1) CA2614420A1 (de)
DE (1) DE602006018738D1 (de)
GB (1) GB0514043D0 (de)
IL (1) IL188639A0 (de)
MX (1) MX2008000342A (de)
NO (1) NO20080219L (de)
WO (1) WO2007007059A1 (de)
ZA (1) ZA200800147B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60133203T3 (de) 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
SI1976521T1 (sl) 2006-01-25 2015-06-30 Insys Therapeutics, Inc. Podjezično fentanilno pršilo
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
WO2009017837A2 (en) 2007-08-02 2009-02-05 Insys Therapeutics Inc. Sublingual fentanyl spray
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil
GB2481728B (en) * 2010-06-30 2012-05-23 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017916C (en) * 1989-06-07 1999-02-02 Minoru Aoki Etoposide preparations
JP2002037735A (ja) * 2000-05-15 2002-02-06 Rohto Pharmaceut Co Ltd カフェイン類の安定化方法および粘膜適用組成物
EP1296649A2 (de) * 2000-06-22 2003-04-02 Pharmasol Limited Pharmazeutische zusammenstzung enthaltend ein opiatanalgetikum
JP2003171311A (ja) * 2001-09-26 2003-06-20 Lion Corp 内服液剤組成物、それを含む内服液剤品
AU2004218876B2 (en) 2003-03-11 2007-08-02 Arakis Ltd. Novel compositions containing fentanyl

Also Published As

Publication number Publication date
GB0514043D0 (en) 2005-08-17
ATE490762T1 (de) 2010-12-15
IL188639A0 (en) 2008-04-13
BRPI0612771A2 (pt) 2010-11-30
JP2009500387A (ja) 2009-01-08
DE602006018738D1 (de) 2011-01-20
WO2007007059A1 (en) 2007-01-18
EP1904032A1 (de) 2008-04-02
CA2614420A1 (en) 2007-01-18
ZA200800147B (en) 2009-07-29
KR20080044232A (ko) 2008-05-20
MX2008000342A (es) 2008-04-02
CN101247788A (zh) 2008-08-20
EP1904032B1 (de) 2010-12-08
AU2006268052A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
IL188639A0 (en) Fentanyl formulation containing an essential oil
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
AR095848A2 (es) Derivados imidazolicos de propionamida moduladores de receptores opioides
NO20081160L (no) Benzimidazoltiofen forbindelser
AR050509A1 (es) Dispositivo de higiene oral
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
EA200802008A1 (ru) Фармацевтические композиции
MX2009003934A (es) Dosificador de dosis unitarias de detergente con componente que suministra fragancia.
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK1594944T3 (da) Rengöringssammensætninger i tabletform
PA8792401A1 (es) Fenilendiaminas
NO20072071L (no) Flytende modulkonstruksjon
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
UA100850C2 (ru) Средство для борьбы с паразитами на животных
DK1740569T3 (da) Imidazol-derivater som TAFla-inhibitorer
EP2077111A4 (de) Antidepressivum
DK1740583T3 (da) Oxadiazolon-derivater som ppar-delta-agonister
SV2006002001A (es) Inhibidores de quinasa ref. x - 16437
EA200501698A1 (ru) Противовспенивающие композиции
WO2006069159A3 (en) Pharmaceutical compositions comprising amorphous benzimidazole compounds
WO2008146883A1 (ja) 睡眠改善剤
DK1931636T3 (da) Isoquinoliner som IGF-1R-inhibitorer
CR11628A (es) ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSUAL If Y DE UN BETA-BLOQUEANTE
MXPA05009602A (es) Composiciones novedosas.
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application